Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-25-000005

Chief Scientific Officer gave up 3,643 shares (to pay taxes)

  • Chief Scientific Officer acquired 8,865 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Humeau Laurent · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Exercise or conversion : show line 1 in the form +3,855 28,192 D
2025-02-26 Shares withheld for taxes : show line 2 in the form −1,584 $1.98 $3,136 26,608 D
2025-02-26 Exercise or conversion : show line 3 in the form +5,010 31,618 D
2025-02-26 Shares withheld for taxes : show line 4 in the form −2,059 $1.98 $4,077 29,559 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-02-26 Exercise or conversion : show line 5 in the form Restricted Stock Unit −3,855 0 D
2025-02-26 Exercise or conversion : show line 6 in the form Restricted Stock Unit −5,010 10,019 D
2025-02-27 Grant or award : show line 7 in the form Common Stock Option +27,402 27,402 D
2025-02-27 Grant or award : show line 8 in the form Restricted Stock Unit +22,098 22,098 D
Loading xslF345X05/wk-form4_1740783954.xml…